drugset
drugset / Trial / NCT01209949

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

NCT01209949 ↗

Phase 4 Completed 30 enrolled Galderma R&D
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess subjects' experiences using Adapalene BPO gel to treat mild to moderate acne vulgaris using efficacy measurements, quality of life instruments, and video diaries.

Timeline

Start
2010-10
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.1 % Topical
Subject Benzoyl Peroxide Other / unclassified 2.5 % Topical

Indications

acne